Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia

NCT05076006 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Cicatricial Alopecia

Interventions

DRUG: PF-06700841
DRUG: Placebo

Sponsor

Emma Guttman

Collaborators

[object Object]